Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting…
Belgium: UCB completes acquisition of Neurona Therapeutics
…
…






